Pharmaceuticals that cost well north of $100,000 for a course of treatment are far from rare these days.The Affordable Care Act, which goes fully into effect next year, could mean that patients with cancer, multiple sclerosis,
rheumatoid arthritis and ...
[Published MSN Money - 2 hours ago]